These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36444273)

  • 1. Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent.
    Rashid F; Ahmad M; Ashfaq UA; Al-Mutairi AA; Al-Hussain SA
    Drug Des Devel Ther; 2022; 16():4043-4060. PubMed ID: 36444273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study.
    Taj S; Ahmad M; Ashfaq UA
    Int J Biol Macromol; 2022 May; 207():507-521. PubMed ID: 35276296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cyclic Sulfonamides with an
    Saddique FA; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Zaki MEA
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2
    Saddique FA; Aslam S; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Taj S; Hussain M; Sung Lee D; Zaki MEA
    Molecules; 2021 May; 26(10):. PubMed ID: 34065194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach.
    Taj S; Ashfaq UA; Ahmad M; Noor H; Ikram A; Ahmed R; Tariq M; Masoud MS; Hasan A
    Sci Rep; 2024 Apr; 14(1):7746. PubMed ID: 38565861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
    Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
    Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
    J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
    Ritu ; Sharma P; Gupta GD; Asati V
    Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
    Singh G; Singh R; Monga V; Mehan S
    Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic potential of Lysiphyllum strychnifolium (Craib) A. Schmitz compounds in human intestinal epithelial Caco-2 cells and molecular docking-based approaches.
    Noonong K; Pranweerapaiboon K; Chaithirayanon K; Surayarn K; Ditracha P; Changklungmoa N; Kueakhai P; Hiransai P; Bunluepuech K
    BMC Complement Med Ther; 2022 Sep; 22(1):235. PubMed ID: 36064352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
    Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
    Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
    Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
    Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
    Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
    BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.